NCT01808417View on ClinicalTrials.gov

NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 21, 2013

Primary Completion Date

April 11, 2014

Study Completion Date

April 7, 2015

Conditions
Esophageal Cancer
Interventions
DRUG

Near Infrared Imaging

The intervention to be administered is the drug indocyanine green.

Trial Locations (2)

02215

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
lead

Dana-Farber Cancer Institute

OTHER

NCT01808417 - NIR-Guided Sentinel Lymph-Node Mapping for Esophageal Cancer | Biotech Hunter | Biotech Hunter